Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

IFF

IFF sells food ingredients business for $4.3 billion

International Flavors & Fragrances is selling its food ingredients business to funds advised by CVC Capital Partners in a deal valuing the unit at about $4.3 billion, equal to roughly 10 times EBITDA.

IFF said it will keep about a 10% minority stake, worth about $200 million, and expects to receive about $3.8 billion in net cash at closing after adjustments, carve-out costs and taxes.

The food ingredients unit generated nearly $3.1 billion in annual sales in 2025 and about $430 million in EBITDA.

IFF said the transaction adds to a series of divestitures that have now reached 13 non-core businesses and nearly $10 billion in gross proceeds. The company plans to use the new cash first for debt reduction, then for share repurchases and reinvestment in higher-return businesses.

The company also reiterated its 2026 outlook. It expects full-year sales of $10.5 billion to $10.8 billion and adjusted operating EBITDA of $2.05 billion to $2.15 billion. It still sees comparable currency-neutral sales growth of 1% to 4% and comparable currency-neutral adjusted operating EBITDA growth of 3% to 8%.

IFF said the deal is expected to close by the end of the second quarter of 2027. As a result of these announcements, the company's shares have moved -1.66% on the market, and are now trading at a price of $74.79. If you want to know more, read the company's complete 8-K report here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS